Regeneron Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2010 | — | $527.8M | $112.6M |
| FY2011 | — | $485.7M | $483.6M |
| FY2012 | — | $1.26B | $230.3M |
| FY2013 | — | $1.96B | $535.6M |
| FY2014 | — | $2.55B | $648.7M |
| FY2015 | — | $3.65B | $809.1M |
| FY2016 | — | $4.45B | $535.2M |
| FY2017 | — | $6.14B | $812.7M |
| FY2018 | — | $8.76B | $1.47B |
| FY2019 | $0 | $11.09B | $1.62B |